02/04/2026 | Press release | Distributed by Public on 02/04/2026 16:30
| Item 1.01. | Entry into a Material Definitive Agreement. |
Forbearance Agreements
As previously reported, between June 6, 2025 and June 9, 2025, Vivakor, Inc. (the "Company") issued convertible promissory notes (the "Lender Notes"), to seven non-affiliated accredited investors (the "Lenders"), in the aggregate principal amount of $5,117,647.06 in connection with a Securities Purchase Agreement entered into by and between the Company and the Lenders (the "Lender SPA"). Under the terms of the Lender SPA and the Lender Notes, the Company received $4,350,000 prior to deducting customary fees.
On January 30, 2026, the Company entered into Forbearance and Note Amendment Agreements (the "Agreements") with the each of the seven investors. As of the date the Agreements were entered into the Company owes approximately $2,242,793 under the Lender Notes, having satisfied approximately $2,874,854 of the aggregate principal amount since the Lender Notes were issued. Under the terms of the Agreements, (i) the parties agreed to extend the maturity date of the Lender Notes until January 31, 2027; (ii) the Company agreed to issue an aggregate of 56,167,665 shares of its restricted common stock (the "Agreement Shares"); (iii) the Company agreed to pay the following aggregate amounts to payoff the Lender Notes: $378,433.25 on or before March 1, 2026, $396,414.53 on or before April 30, 2026, $258,903.84 on or before June 30, 2026, $454,796.89 on or before July 31, 2026, $17,433.25 on or before September 30, 2026, $356,193.98 on or before October 31, 2026, $372,627.23 on or before January 31, 2027; and (iv) no conversions will be permitted under the Lender Notes unless the Company either fails to pay the Lender Notes in accordance with the above payment terms or the Company fails to get re-listed on Nasdaq on or before February 28, 2026, which date will be extended if the only requirement for the Company to get re-listed is the completion of a reverse stock split of the Company's common stock so long as the Company is in the process of completing the reverse stock split.
Item 1.01 of this Current Report on Form 8-K contains only a brief description of the material terms of, and does not purport to be a complete description of, the rights and obligations of the parties to the agreements in connection with the Agreements, and such description is qualified in its entirety by reference to the full text of the Form of Forbearance and Note Amendment Agreement and its exhibits are attached hereto as Exhibit 10.1.
| Item 3.02 | Unregistered Sales of Equity Securities |
As set forth in Item 1.01, the Company entered into the Agreements and will issue the Agreement Shares. The Agreement Shares were issued as restricted stock with a standard Rule 144 restrictive legend. The issuances of the foregoing securities were exempt from registration pursuant to Section 4(a)(2) of the Securities Act promulgated thereunder as the Lenders are accredited investors and familiar with our operations, as set forth in the Agreements.